Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus.

Harrison EM, Ba X, Coll F, Blane B, Restif O, Carvell H, Köser CU, Jamrozy D, Reuter S, Lovering A, Gleadall N, Bellis KL, Uhlemann AC, Lowy FD, Massey RC, Grilo IR, Sobral R, Larsen J, Rhod Larsen A, Vingsbo Lundberg C, Parkhill J, Paterson GK, Holden MTG, Peacock SJ, Holmes MA.

Nat Microbiol. 2019 Oct;4(10):1680-1691. doi: 10.1038/s41564-019-0471-0. Epub 2019 Jun 24.

PMID:
31235959
2.

Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007 - 2015.

Austin ED, Sullivan SS, Macesic N, Mehta M, Miko BA, Nematollahi S, Shi Q, Lowy FD, Uhlemann AC.

Clin Infect Dis. 2019 Jun 11. pii: ciz498. doi: 10.1093/cid/ciz498. [Epub ahead of print]

PMID:
31185081
3.

Topical vancomycin for neurosurgery wound prophylaxis: an interim report of a randomized clinical trial on drug safety in a diverse neurosurgical population.

Radwanski RE, Christophe BR, Pucci JU, Martinez MA, Rothbaum M, Bagiella E, Lowy FD, Knopman J, Connolly ES.

J Neurosurg. 2018 Dec 1:1-8. doi: 10.3171/2018.6.JNS172500. [Epub ahead of print]

PMID:
30554184
4.

New York City House Mice (Mus musculus) as Potential Reservoirs for Pathogenic Bacteria and Antimicrobial Resistance Determinants.

Williams SH, Che X, Paulick A, Guo C, Lee B, Muller D, Uhlemann AC, Lowy FD, Corrigan RM, Lipkin WI.

MBio. 2018 Apr 17;9(2). pii: e00624-18. doi: 10.1128/mBio.00624-18.

5.

Topical vancomycin to reduce surgical-site infections in neurosurgery: Study protocol for a multi-center, randomized controlled trial.

Jonokuchi AJ, Knopman J, Radwanski RE, Martinez MA, Taylor BES, Rothbaum M, Sullivan S, Robison TR, Lo E, Christophe BR, Bruce EM, Khan S, Kellner CP, Sigounas D, Youngerman B, Bagiella E, Angevine PD, Lowy FD, Sander Connolly E.

Contemp Clin Trials. 2018 Jan;64:195-200. doi: 10.1016/j.cct.2017.10.004. Epub 2017 Oct 10.

PMID:
29030268
6.

Lactobacillus rhamnosus Endocarditis After Upper Endoscopy.

Aaron JG, Sobieszczyk ME, Weiner SD, Whittier S, Lowy FD.

Open Forum Infect Dis. 2017 May 2;4(2):ofx085. doi: 10.1093/ofid/ofx085. eCollection 2017 Spring.

7.

Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection.

Sullivan SB, Austin ED, Stump S, Mathema B, Whittier S, Lowy FD, Uhlemann AC.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00316-17. doi: 10.1128/AAC.00316-17. Print 2017 Jul.

8.

Correspondence analysis to evaluate the transmission of Staphylococcus aureus strains in two New York State maximum-security prisons.

Befus M, Mukherjee DV, Herzig CTA, Lowy FD, Larson E.

Epidemiol Infect. 2017 Jul;145(10):2161-2165. doi: 10.1017/S0950268817000942. Epub 2017 May 16.

PMID:
28506332
9.

The Surface Protein SdrF Mediates Staphylococcus epidermidis Adherence to Keratin.

Trivedi S, Uhlemann AC, Herman-Bausier P, Sullivan SB, Sowash MG, Flores EY, Khan SD, Dufrêne YF, Lowy FD.

J Infect Dis. 2017 Jun 15;215(12):1846-1854. doi: 10.1093/infdis/jix213.

10.

Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.

Doernberg SB, Lodise TP, Thaden JT, Munita JM, Cosgrove SE, Arias CA, Boucher HW, Corey GR, Lowy FD, Murray B, Miller LG, Holland TL; Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828. Review.

11.

Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light.

Buonanno M, Ponnaiya B, Welch D, Stanislauskas M, Randers-Pehrson G, Smilenov L, Lowy FD, Owens DM, Brenner DJ.

Radiat Res. 2017 Apr;187(4):483-491. doi: 10.1667/RR0010CC.1. Epub 2017 Feb 22.

12.

Evolutionary Dynamics of Pandemic Methicillin-Sensitive Staphylococcus aureus ST398 and Its International Spread via Routes of Human Migration.

Uhlemann AC, McAdam PR, Sullivan SB, Knox JR, Khiabanian H, Rabadan R, Davies PR, Fitzgerald JR, Lowy FD.

MBio. 2017 Jan 17;8(1). pii: e01375-16. doi: 10.1128/mBio.01375-16.

13.

Staphylococcus epidermidis Protection Against Staphylococcus aureus Colonization in People Living With Human Immunodeficiency Virus in an Inner-City Outpatient Population: A Cross-Sectional Study.

Sullivan SB, Kamath S, McConville TH, Gray BT, Lowy FD, Gordon PG, Uhlemann AC.

Open Forum Infect Dis. 2016 Dec 20;3(4):ofw234. doi: 10.1093/ofid/ofw234. eCollection 2016 Oct.

14.

HIV and colonization with Staphylococcus aureus in two maximum-security prisons in New York State.

Befus MB, Miko BA, Herzig CT, Keleekai N, Mukherjee DV, Larson E, Lowy FD.

J Infect. 2016 Dec;73(6):568-577. doi: 10.1016/j.jinf.2016.08.016. Epub 2016 Sep 1.

PMID:
27592264
15.

A Novel MSCRAMM Subfamily in Coagulase Negative Staphylococcal Species.

Arora S, Uhlemann AC, Lowy FD, Hook M.

Front Microbiol. 2016 Apr 29;7:540. doi: 10.3389/fmicb.2016.00540. eCollection 2016.

16.

Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection.

Austin ED, Sullivan SB, Whittier S, Lowy FD, Uhlemann AC.

Open Forum Infect Dis. 2016 Apr 6;3(2):ofw072. doi: 10.1093/ofid/ofw072. eCollection 2016 Mar.

17.

Association of Environmental Contamination in the Home With the Risk for Recurrent Community-Associated, Methicillin-Resistant Staphylococcus aureus Infection.

Knox J, Sullivan SB, Urena J, Miller M, Vavagiakis P, Shi Q, Uhlemann AC, Lowy FD.

JAMA Intern Med. 2016 Jun 1;176(6):807-15. doi: 10.1001/jamainternmed.2016.1500.

18.

Preoperative chemotherapy and corticosteroids: independent predictors of cranial surgical-site infections.

Lieber BA, Appelboom G, Taylor BE, Lowy FD, Bruce EM, Sonabend AM, Kellner C, Connolly ES Jr, Bruce JN.

J Neurosurg. 2016 Jul;125(1):187-95. doi: 10.3171/2015.4.JNS142719. Epub 2015 Nov 6.

PMID:
26544775
19.

Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of Staphylococcus aureus.

Laabei M, Uhlemann AC, Lowy FD, Austin ED, Yokoyama M, Ouadi K, Feil E, Thorpe HA, Williams B, Perkins M, Peacock SJ, Clarke SR, Dordel J, Holden M, Votintseva AA, Bowden R, Crook DW, Young BC, Wilson DJ, Recker M, Massey RC.

PLoS Biol. 2015 Sep 2;13(9):e1002229. doi: 10.1371/journal.pbio.1002229. eCollection 2015.

20.

Obesity as a Determinant of Staphylococcus aureus Colonization Among Inmates in Maximum-Security Prisons in New York State.

Befus M, Lowy FD, Miko BA, Mukherjee DV, Herzig CT, Larson EL.

Am J Epidemiol. 2015 Sep 15;182(6):494-502. doi: 10.1093/aje/kwv062. Epub 2015 Aug 19.

21.

Prevalence and Predictors of Chronic Health Conditions of Inmates Newly Admitted to Maximum Security Prisons.

Bai JR, Befus M, Mukherjee DV, Lowy FD, Larson EL.

J Correct Health Care. 2015 Jul;21(3):255-64. doi: 10.1177/1078345815587510.

22.

Staphylococcus aureus infections: transmission within households and the community.

Knox J, Uhlemann AC, Lowy FD.

Trends Microbiol. 2015 Jul;23(7):437-44. doi: 10.1016/j.tim.2015.03.007. Epub 2015 Apr 9. Review.

23.

Epidemiological and biological determinants of Staphylococcus aureus clinical infection in New York State maximum security prisons.

Miko BA, Befus M, Herzig CT, Mukherjee DV, Apa ZL, Bai RY, Tanner JP, Gage D, Genovese M, Koenigsmann CJ, Larson EL, Lowy FD.

Clin Infect Dis. 2015 Jul 15;61(2):203-10. doi: 10.1093/cid/civ242. Epub 2015 Mar 25.

24.

In vitro effect of temperature on the conformational structure and collagen binding of SdrF, a Staphylococcus epidermidis adhesin.

Di Poto A, Papi M, Trivedi S, Maiorana A, Gavazzo P, Vassalli M, Lowy FD, De Spirito M, Montanaro L, Imbriani M, Arciola CR, Visai L.

Appl Microbiol Biotechnol. 2015 Jul;99(13):5593-603. doi: 10.1007/s00253-015-6456-x. Epub 2015 Feb 17.

PMID:
25683665
25.

Molecular characterization of methicillin-resistant Staphylococcus aureus clinical isolates obtained from the Rikers Island Jail System from 2009 to 2013.

Tanner J, Lin Y, Kornblum J, Herzig CT, Bystritsky R, Uhlemann AC, Lowy FD.

J Clin Microbiol. 2014 Aug;52(8):3091-4. doi: 10.1128/JCM.01129-14. Epub 2014 Jun 4.

26.

Community-associated methicillin-resistant Staphylococcus aureus transmission in households of infected cases: a pooled analysis of primary data from three studies across international settings.

Knox J, Van Rijen M, Uhlemann AC, Miller M, Hafer C, Vavagiakis P, Shi Q, Johnson PD, Coombs G, Kluytmans-Van Den Bergh M, Kluytmans J, Bennett CM, Lowy FD.

Epidemiol Infect. 2015 Jan;143(2):354-65. doi: 10.1017/S0950268814000983. Epub 2014 Apr 24.

27.

Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community.

Uhlemann AC, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MT, Peacock SJ, Lowy FD.

Proc Natl Acad Sci U S A. 2014 May 6;111(18):6738-43. doi: 10.1073/pnas.1401006111. Epub 2014 Apr 21.

28.

Concordance between medical records and interview data in correctional facilities.

Bai JR, Mukherjee DV, Befus M, Apa Z, Lowy FD, Larson EL.

BMC Med Res Methodol. 2014 Apr 9;14:50. doi: 10.1186/1471-2288-14-50.

29.

207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studies.

Buonanno M, Randers-Pehrson G, Bigelow AW, Trivedi S, Lowy FD, Spotnitz HM, Hammer SM, Brenner DJ.

PLoS One. 2013 Oct 16;8(10):e76968. doi: 10.1371/journal.pone.0076968. eCollection 2013.

30.

Reply to Gandra et al.

Uhlemann AC, Lowy FD.

Clin Infect Dis. 2014 Jan;58(2):307-8. doi: 10.1093/cid/cit685. Epub 2013 Oct 21. No abstract available.

31.

Methicillin-resistant Staphylococcus aureus: where is it coming from and where is it going?

Lowy FD.

JAMA Intern Med. 2013 Nov 25;173(21):1978-9. doi: 10.1001/jamainternmed.2013.8277. No abstract available.

PMID:
24042964
32.

Prevalence and risk factors for Staphylococcus aureus colonization in individuals entering maximum-security prisons.

Mukherjee DV, Herzig CT, Jeon CY, Lee CJ, Apa ZL, Genovese M, Gage D, Koenigsmann CJ, Lowy FD, Larson EL.

Epidemiol Infect. 2014 Mar;142(3):484-93. doi: 10.1017/S0950268813001544. Epub 2013 Jun 28.

33.

Emergence of sequence type 398 as a community- and healthcare-associated methicillin-susceptible staphylococcus aureus in northern Manhattan.

Uhlemann AC, Hafer C, Miko BA, Sowash MG, Sullivan SB, Shu Q, Lowy FD.

Clin Infect Dis. 2013 Sep;57(5):700-3. doi: 10.1093/cid/cit375. Epub 2013 May 31.

34.

Asymptomatic carriage of sequence type 398, spa type t571 methicillin-susceptible Staphylococcus aureus in an urban jail: a newly emerging, transmissible pathogenic strain.

David MZ, Siegel J, Lowy FD, Zychowski D, Taylor A, Lee CJ, Boyle-Vavra S, Daum RS.

J Clin Microbiol. 2013 Jul;51(7):2443-7. doi: 10.1128/JCM.01057-13. Epub 2013 May 8.

35.

Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus.

Uhlemann AC, Otto M, Lowy FD, DeLeo FR.

Infect Genet Evol. 2014 Jan;21:563-74. doi: 10.1016/j.meegid.2013.04.030. Epub 2013 May 3. Review.

36.

Is environmental contamination associated with Staphylococcus aureus clinical infection in maximum security prisons?

Miko BA, Herzig CT, Mukherjee DV, Befus M, Apa ZL, Bai RY, Lee CJ, Uhlemann AC, Larson EL, Lowy FD.

Infect Control Hosp Epidemiol. 2013 May;34(5):540-2. doi: 10.1086/670218. No abstract available.

37.

Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation.

Harris B, Lowy FD, Stover DE, Arcasoy SM.

Ann Am Thorac Soc. 2013 Feb;10(1):39-49. doi: 10.1513/AnnalsATS.201212-114FR. Review.

PMID:
23509331
38.

Prospective, multicenter study of ventricular assist device infections.

Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y, Goldstein DJ, Dembitsky WP, Giacalone JC, Ferrante J, Ascheim DD, Moskowitz AJ, Rose EA, Gelijns AC, Lowy FD; Ventricular Assist Device Infection Study Group.

Circulation. 2013 Feb 12;127(6):691-702. doi: 10.1161/CIRCULATIONAHA.112.128132. Epub 2013 Jan 11.

39.

Molecular characterization of methicillin-susceptible Staphylococcus aureus clinical isolates in the United States, 2004 to 2010.

Miko BA, Hafer CA, Lee CJ, Sullivan SB, Hackel MA, Johnson BM, Whittier S, Della-Latta P, Uhlemann AC, Lowy FD.

J Clin Microbiol. 2013 Mar;51(3):874-9. doi: 10.1128/JCM.00923-12. Epub 2013 Jan 2.

40.

Environmental contamination as a risk factor for intra-household Staphylococcus aureus transmission.

Knox J, Uhlemann AC, Miller M, Hafer C, Vasquez G, Vavagiakis P, Shi Q, Lowy FD.

PLoS One. 2012;7(11):e49900. doi: 10.1371/journal.pone.0049900. Epub 2012 Nov 13.

41.

Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community households.

Uhlemann AC, Kennedy AD, Martens C, Porcella SF, Deleo FR, Lowy FD.

Genome Biol Evol. 2012;4(12):1275-85. doi: 10.1093/gbe/evs094.

42.

Staphylococcus aureus CC398 clade associated with human-to-human transmission.

McCarthy AJ, van Wamel W, Vandendriessche S, Larsen J, Denis O, Garcia-Graells C, Uhlemann AC, Lowy FD, Skov R, Lindsay JA.

Appl Environ Microbiol. 2012 Dec;78(24):8845-8. doi: 10.1128/AEM.02398-12. Epub 2012 Oct 5.

43.

The role of ionic interactions in the adherence of the Staphylococcus epidermidis adhesin SdrF to prosthetic material.

Toba FA, Visai L, Trivedi S, Lowy FD.

FEMS Microbiol Lett. 2013 Jan;338(1):24-30. doi: 10.1111/1574-6968.12018. Epub 2012 Nov 2.

44.

Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.

Hafer C, Lin Y, Kornblum J, Lowy FD, Uhlemann AC.

Antimicrob Agents Chemother. 2012 Nov;56(11):5845-51. doi: 10.1128/AAC.01139-12. Epub 2012 Sep 4.

45.

Challenges and strategies for research in prisons.

Apa ZL, Bai R, Mukherejee DV, Herzig CT, Koenigsmann C, Lowy FD, Larson EL.

Public Health Nurs. 2012 Sep-Oct;29(5):467-72. doi: 10.1111/j.1525-1446.2012.01027.x. Epub 2012 May 25.

46.

High prevalence of colonization with Staphylococcus aureus clone USA300 at multiple body sites among sexually transmitted disease clinic patients: an unrecognized reservoir.

Miko BA, Uhlemann AC, Gelman A, Lee CJ, Hafer CA, Sullivan SB, Shi Q, Miller M, Zenilman J, Lowy FD.

Microbes Infect. 2012 Oct;14(12):1040-3. doi: 10.1016/j.micinf.2012.06.004. Epub 2012 Jun 21.

47.

Methicillin-susceptible Staphylococcus aureus ST398, New York and New Jersey, USA.

Mediavilla JR, Chen L, Uhlemann AC, Hanson BM, Rosenthal M, Stanak K, Koll B, Fries BC, Armellino D, Schilling ME, Weiss D, Smith TC, Lowy FD, Kreiswirth BN.

Emerg Infect Dis. 2012 Apr;18(4):700-2. doi: 10.3201/eid1804.111419. No abstract available.

48.

Staphylococcus epidermidis colonization is highly clonal across US cardiac centers.

Gordon RJ, Miragaia M, Weinberg AD, Lee CJ, Rolo J, Giacalone JC, Slaughter MS, Pappas P, Naka Y, Tector AJ, de Lencastre H, Lowy FD.

J Infect Dis. 2012 May 1;205(9):1391-8. doi: 10.1093/infdis/jis218. Epub 2012 Mar 29.

49.

Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties.

Uhlemann AC, Porcella SF, Trivedi S, Sullivan SB, Hafer C, Kennedy AD, Barbian KD, McCarthy AJ, Street C, Hirschberg DL, Lipkin WI, Lindsay JA, DeLeo FR, Lowy FD.

MBio. 2012 Feb 28;3(2). pii: e00027-12. doi: 10.1128/mBio.00027-12. Print 2012.

50.

Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA).

Skov R, Christiansen K, Dancer SJ, Daum RS, Dryden M, Huang YC, Lowy FD.

Int J Antimicrob Agents. 2012 Mar;39(3):193-200. doi: 10.1016/j.ijantimicag.2011.09.029. Epub 2012 Jan 9. Review.

PMID:
22226649

Supplemental Content

Support Center